SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently experiencing significant trading volume and renewed community speculation as traders rotate into Japanese blockchain projects and IoT-focused assets. While investors remain divided by the token's historical price volatility, the conversation is dominated by technical breakout potential and anticipation of long-term ecosystem development despite broader market uncertainty.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad ($GIGA) is experiencing a wave of community optimism driven by its recent expansion into real-world fitness supplements and a durable, long-standing cult-like following on Solana. Investors are actively debating its potential for a massive repricing, frequently comparing its long-term growth trajectory to established market leaders while highlighting its low market cap as a high-risk, high-reward asymmetric opportunity.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently trending due to intense community debate over its business model, with many investors viewing the stock as a real estate and royalty machine rather than just a fast-food chain. While supporters highlight its long-term compounding and dividend reliability, significant volatility is being driven by customer and investor backlash regarding value menu pricing and recent management commentary.

Direxion Shares ETF Trust - Direxion Daily MU Bull 2X ETF

Direxion Daily MU Bull 2X Shares

Investors are flocking to this leveraged ETF as a high-volatility vehicle to capture momentum in the semiconductor and memory chip sector, driven by bullish narratives surrounding supply shortages and production demand. The community is actively debating the risks and rewards of maintaining leveraged exposure during rapid price swings, with many traders sharing strategies on how to navigate the volatility through short-term positioning.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is currently a focal point for investors as the broader Bitcoin market navigates heightened volatility, driven by speculation over geopolitical tensions in the Middle East and shifting institutional sentiment regarding crypto's role as a digital reserve asset. Community discussions are heavily centered on Bitcoin's price action at key support levels and the potential impact of ETF flows on market liquidity amid conflicting macroeconomic signals.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending due to anticipation surrounding late-breaking clinical data for the CHOPIN trial, which is expected to showcase the efficacy of its HEPZATO KIT in combination therapies. The community is actively discussing the companys expansion into additional indications like metastatic colorectal and breast cancer, while debating the significance of recent hospital network growth versus the stock's stagnant price action and short-term revenue fluctuations.

Amphenol Corp. engages in the design, manufacture, and marketing of electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products, and specialty cable. It operates through the following segments: Harsh Environment Solutions, Communications Solutions, and Interconnect and Sensor Systems. The Harsh Environment Solutions segment manufactures and markets a broad range of ruggedized interconnect products, including connectors and interconnect systems, printed circuits and printed circuit assemblies, and other products. The Communications Solutions segment focuses on the design, manufacture, and marketing of connector and interconnect systems, including radio frequency, power, fiber optic, and other products, together with antennas. The Interconnect and Sensor Systems segment is involved in the design, manufacture, and marketing of sensors, sensor-based systems, connectors, and value-add interconnect systems. The company was founded by Schmitt J. Arthur in 1932 and is headquartered in Wallingford, CT.

Amphenol Corp. - Ordinary Shares - Class A

Amphenol is drawing significant investor interest as it continues to capitalize on strong demand for data center infrastructure and AI-related interconnect technology, despite some community concerns regarding executive stock sales and high valuation multiples. Market sentiment is split, with bulls pointing to the company's robust backlog and order growth as proof of its long-term compounding potential, while bears remain focused on its premium price-to-earnings ratio and broader sector volatility.

Ethereum Classic

Ethereum Classic is currently trending as investors debate the potential for an altcoin rally, with the community closely tracking its strength relative to Bitcoin and other major assets. Discussions are polarized, balancing optimism around its proof-of-work model and long-term utility against frustrations over its extended period of price stagnation.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma Inc. is trending as the community debates its transition from a speculative R&D-stage company to a commercial player, with investors closely watching for foundry partnerships and scalable manufacturing validation. Market discussion is heavily focused on the company's potential role in the AI and photonics infrastructure space, juxtaposed against concerns over stock dilution from at-the-market offerings and high short interest.

Roundhill ETF Trust - Roundhill Memory ETF

The $DRAM ETF is trending as investors rotate into memory and storage leaders like SK Hynix, Samsung, and Micron to capitalize on a persistent AI-driven supply bottleneck. The community is actively discussing the ETF's concentrated structure as a direct, non-leveraged beta proxy for the memory super-cycle, while debating strategies for manual replication versus holding the fund directly.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Spyre Therapeutics (NASDAQ:SYRE) Price Target Raised to $97.00 at Citigroup

Citigroup upped their target price on shares of Spyre Therapeutics from $64.00 to $97.00 and gave the company a "buy" rating in a research note on Wednesday...

Insider Selling: Spyre Therapeutics (NASDAQ:SYRE) CEO Sells 15,000 Shares of Stock

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) CEO Cameron Turtle sold 15,000 shares of the company's stock in a transaction dated Friday, May 1st. The stock was sold at an average price of...

Spyre Therapeutics (NASDAQ:SYRE) Insider Sells $5,600,809.50 in Stock

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) insider Sheldon Sloan sold 78,333 shares of Spyre Therapeutics stock in a transaction on Friday, May 1st. The shares were sold at an average...

Insider Selling: Spyre Therapeutics (NASDAQ:SYRE) CFO Sells 12,500 Shares of Stock

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) CFO Scott Burrows sold 12,500 shares of Spyre Therapeutics stock in a transaction on Friday, May 1st. The shares were sold at an average price...

Spyre Therapeutics (NASDAQ:SYRE) Trading Down 6.3%  - Here's What Happened

Spyre Therapeutics (NASDAQ:SYRE) Trading Down 6.3% - Here's Why...

Pictet Asset Management Holding SA Cuts Stake in Spyre Therapeutics, Inc. $SYRE

Pictet Asset Management Holding SA cut its holdings in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) by 11.8% during the 4th quarter, according to the company in its most recent Form...

Spyre Therapeutics (NASDAQ:SYRE) Reaches New 1-Year High - Here's What Happened

Spyre Therapeutics (NASDAQ:SYRE) Sets New 1-Year High - Still a Buy...

Universal Beteiligungs und Servicegesellschaft mbH Raises Stake in Spyre Therapeutics, Inc. $SYRE

Universal Beteiligungs und Servicegesellschaft mbH boosted its stake in Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) by 55.0% in the fourth quarter, according to the company in its most...

Wall Street Zen Downgrades Spyre Therapeutics (NASDAQ:SYRE) to Sell

Wall Street Zen lowered Spyre Therapeutics from a "hold" rating to a "sell" rating in a research report on Sunday...

SYRE Stock Jumps More Than 70% in a Month: What Is Driving This Rally?

Spyre Therapeutics' stock rises 73% in a month after mid-stage data show strong efficacy and safety for SPY001 in ulcerative colitis, boosting investor optimism.

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.

Spyre Therapeutics Inc.

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

SYRE
Spyre Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest SYRE News

SYRESpyre Therapeutics Inc